Invention Grant
- Patent Title: Organic compounds
- Patent Title (中): 有机化合物
-
Application No.: US13128825Application Date: 2009-11-10
-
Publication No.: US08530522B2Publication Date: 2013-09-10
- Inventor: Guido Jordine , Michael Mutz
- Applicant: Guido Jordine , Michael Mutz
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Andrew Holmes; Karen DeBenedictis
- Priority: EP08168865 20081111
- International Application: PCT/EP2009/064891 WO 20091110
- International Announcement: WO2010/055028 WO 20100520
- Main IPC: A61K31/137
- IPC: A61K31/137 ; C07C215/28 ; A61P37/06
Abstract:
The present invention relates to crystalline forms and hydrates of 2-Amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol, and to the use thereof, in particular in the treatment or prevention of various autoimmune conditions.
Public/Granted literature
- US20110229501A1 ORGANIC COMPOUNDS Public/Granted day:2011-09-22
Information query
